This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and microvillus inclusion disease (MVID) in the US, EU, and/or Middle East/North Africa regions
Availability of first IIT proof-of-concept results potentially in H1 2025
Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan-Drug Designation by the FDA and the European Medicines Agency (EMA) for both SBS-IF and MVID
Read More
The global leader in dental imaging technologies will showcase the latest innovations added to its digital ecosystem - a suite of tools and software designed to connect the entire digital workflow from diagnosis to delivery.
Read More
New Mobile App to Offer Enhanced Features for Fans to Connect with Athletes, Celebrities, and Influencers, Opening Up New Revenue Streams for Fantribe and Tritent International
Read More
Blockchain Pioneer and Public Markets Executive Frank Yglesias Appointed CEO of Pineapple Express Cannabis Company (OTC: PNXP); Strategic Relocation to Atlanta Tech Hub Signals Transformation into Cannabis Authentication Technology Leader, Launching Revolutionary GROOVY Platform for Product Safety and Consumer Rewards.
Read More
Compassion Center is proud to partner with Psychedelic Science 2025 (PS2025), the premier global conference on psychedelic research and innovation hosted by MAPS. As an exhibitor, Compassion Center will highlight pioneering psychedelic-assisted programs, clinical research pathways, and strategic partnerships that advance mental health and integrative medicine. Visitors can explore breakthroughs in PTSD, addiction, and neurodegenerative disease treatments while engaging with leaders driving equitable access to transformative therapies.
Read More
Compassion Center proudly honors Dr. David Bearman for his pioneering work in medical cannabis, integrative healthcare, and patient advocacy. As Dr. Bearman retires, his legacy lives on through initiatives like CBCCERN, TeachOneServe10.org, and IntegrativeECS, reshaping care for millions. Amie Lindsay steps into a new leadership role, driving national expansion while preserving Compassion Center's mission: providing compassionate, evidence-based care and advancing integrative medicine across the U.S.
Read More
Compassion Center urges media outlets to report accurately on the DEA's active cannabis rescheduling hearings, emphasizing the importance of factual coverage during this pivotal regulatory process. Suggesting that the hearing is cancelled is a lie. Misinformation like this risks undermining patient access, public trust, and informed policymaking as the DEA evaluates moving cannabis to a Schedule III substance under the Controlled Substances Act (CSA). Compassion Center remains committed to providing expert insights and advocating for patie
Read MoreIdentity theft and credit reporting mistakes tied to auto loans are leaving consumers with financial headaches. Petroff Amshen LLP is stepping in to offer legal solutions that help people regain control of their credit reports and financial well-being.
Read More
As food is the #1 impact on our health, it's more important than ever that we know what's in our food so we can take control of our health. BetterBites™ hits the App Store today to dramatically simplify the process of making healthier food choices so you can Feel Better, Look Better, and Do More!
Read More
The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Edison International (NYSE:EIX) shares. Investors who purchased shares of Edison International (NYSE:EIX) prior to February 2021 and continue to hold any of those NYSE: EIX shares also have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
